Testosterone Cypionate/Anastrozole Injectable Recalled for Lack of Sterility Assurance
Vita Pharmacy (Talon Compounding Pharmacy) is recalling two lots of testosterone cypionate 200mg/anastrozole 0.7mg/ml injectable solution due to lack of assurance of sterility. The product was distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this as a Class II recall involving a compounded injectable pharmaceutical without assured sterility. Class II recalls, particularly those involving sterile injectables where microbial contamination poses risk of serious infection, meet the Severe threshold even without reported illness.
Plain-English summary
Vita Pharmacy, LLC, doing business as Talon Compounding Pharmacy, is recalling testosterone cypionate 200mg/anastrozole 0.7mg/ml in oil injectable solution due to lack of assurance of sterility.
The affected product includes two vials with the following lot information: Lot T1007202021:25 with BUD (beyond use date) of 01/16/2022, and Lot T1009102021:46 with BUD of 03/09/2022. This is a prescription-only medication manufactured by Vita Pharmacy, LLC, located at 2950 Thousand Oaks Drive Suite 25, San Antonio, Texas.
The product was distributed throughout the United States, including Washington, D.C. and Puerto Rico. Patients who have received this medication should contact their healthcare provider to determine whether they were affected and to discuss any appropriate follow-up care.
The recalled product
- Product
- TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 0.7MG/ML IN OIL INJECTABLE, Rx only, Talon Compounding Pharmacy, 2950 Thousand Oaks Drive Ste 25, San Antonio, Texas 78247
- Manufacturer
- Vita Pharmacy, LLC dba Talon Compounding Pharmacy
- Category
- Drug — Compounded Injectable
- Hazard
- sterility-failure
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: T1007202021:25 BUD: 01/16/2022
- T1009102021:46 BUD: 03/09/2022
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27